Stay updated with breaking news from David Wald. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Aclaimant, the leading, proactive RMIS platform, is proud to partner with The Liberty Company, one of the fastest growing privately held...
The partnership combines Aclaimant's streamlined FNOL reporting with powerful analytics to support Liberty's risk management services for insureds...
The home video release plans are set for this series.
Chimeric Therapeutics Ltd (ASX:CHM) is fairly priced at $0.71 per share based on recent developments, including its agreement with Case Western University...
Chimeric Therapeutics Ltd (ASX:CHM) CEO and managing director Jennifer Chow speaks with Andrew Scott from Proactive about entering into a sponsored research...